ARK Genomic Revolution ETF
ETFYour view on ARKG
ARK Genomic Revolution ETF
ETFARKSentiment
AUM (USD)
$1.56B
Expense Ratio
0.75%
Holdings
10
Sentiment
Overview for ARK Genomic Revolution ETF
- Fund Type
- ETF
- Fund Issuer
- ARK
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- October 31, 2014
- Domicile
- US
- Website
- ark-funds.com/funds/arkg
- Fund Type
- ETF
- Fund Issuer
- ARK
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- October 31, 2014
- Domicile
- US
- Website
- ark-funds.com/funds/arkg
- Fund Type
- ETF
- Fund Issuer
- ARK
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- October 31, 2014
- Domicile
- US
- Website
- ark-funds.com/funds/arkg
About this fund
The ARKG fund operates as an actively managed Exchange Traded Fund (ETF), aiming to achieve significant capital appreciation over an extended period. Its investment strategy involves committing a minimum of 80% of its total assets, under typical market conditions, to equity secur…
ARKG Stock Price
Key Facts
EquityExpense Ratio
0.75%
AUM
$1.56B
Fund Details
Expense Ratio
0.75%
Assets Under Management
$1.56B
NAV
$47.11 USD
Holdings
10
Average Volume
3.39M
Inception Date
October 31, 2014
Asset Class
Equity
Fund Issuer
ARK
Domicile
US
ISIN
US00214Q3020
CUSIP
00214Q302
NAV Currency
USD
Expense Ratio
0.75%
Assets Under Management
$1.56B
NAV
$47.11 USD
Holdings
10
Average Volume
3.39M
Inception Date
October 31, 2014
Asset Class
Equity
Fund Issuer
ARK
Domicile
US
ISIN
US00214Q3020
CUSIP
00214Q302
NAV Currency
USD
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
News
this company valued side by side against its closest peers. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.